Jul 16, 2010 | Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory Operations, Laboratory Pathology, Management & Operations
TLA and other laboratory automation solutions help clinical labs cope with shortage medical technologists
It’s been about 15 years since the first total laboratory automation (TLA) solutions were introduced into clinical laboratories in the United States. Starting in the mid-1990s, several commercial laboratory companies and a handful of hospital laboratories took the plunge and installed total laboratory automation systems in their high volume core laboratories.
Today, hundreds of clinical pathology laboratories in the United States have turned to laboratory automation as one approach to improving quality, reducing turnaround times for lab test results, to save money, and to improve staff productivity. Starting around the year 2000, an ever-growing number of in vitro diagnostics (IVD) manufacturers and other companies have introduced laboratory automation solutions and systems. This has widened the choices of medical laboratories, who often prefer a task-targeted automation solution to the “whole enchilada”—total laboratory automation.
(more…)
Jul 14, 2010 | Laboratory Instruments & Laboratory Equipment, Laboratory Pathology
New molecular point-of-care testing systems already being tested in several African countries
Pathologists will be interested to learn that sophisticated point-of-care molecular diagnostics testing is now being done on livestock in farms. This is a giant leap forward for point-of-care testing, as there are now commercially available suitcase-sized devices used to perform molecular diagnostic tests for avian flu in livestock. These molecular testing systems are undergoing trials in Africa, primarily Sudan and Kenya.
Development of the devices was partially funded through a joint project of the International Atomic Energy Agency (IAEA) and the Food and Agriculture Organization (FAO). The organizations are concerned about trans-boundary animal diseases that, like the avian flu, can cross from one species to another. These agencies funded research to develop molecular diagnostic methods to rapidly identify such diseases. The avian flu test is the first to make use of this new molecular technology.
(more…)
Jun 22, 2010 | Laboratory News, Laboratory Pathology, News From Dark Daily
Lab-savvy lawyers tackle overlooked issues involving non-compete covenants, protection of client lists, and effective partnership agreements
Unbeknownst to many owners of clinical laboratories and pathology groups, several developments have created new risks for the most important business assets of these organizations. Experts involved in legal and financial consulting for laboratories advise their clients to take definitive steps to prevent direct loss or any significant erosion in the value of these valuable business assets.
Too often, laboratory owners and the pathologist-partners of group practices find the value of their business needlessly reduced because they failed to take simple—but necessary—actions to fully protect their assets. That is not surprising, because many of a laboratory’s highest-value assets are represented by contracts with employees and partners, agreements on trade secrets, non-compete covenants with executives and sales representatives, and even something as basic as employee handbooks.
(more…)
Jun 16, 2010 | Laboratory News, Laboratory Pathology
American Society of Clinical Pathology recognizes top-performing clinical pathology labs
When it comes to patient satisfaction rankings in hospitals, the clinical pathology laboratory is often ranked at the very bottom of the 10 clinical service categories measured by patient survey systems such as Press Ganey Associates. This bottom-tier ranking is undeserved, but happens for a logical reason.
For most patients, their only interaction with the hospital’s laboratory is when a phlebotomist sticks them with a needle to collect blood. Most patients find needle sticks to be uncomfortable and unpleasant. Further, a significant number of patients are afraid of needles.
(more…)
Jun 14, 2010 | Laboratory News, Laboratory Pathology
Healthscope bids also fuel speculation of a big clinical pathology transaction
Last week in Australia, investment insiders shared rumors that Quest Diagnostics Incorporated (NYSE: DGX) was interested in acquiring Sonic Healthcare Ltd. (ASX: SHL). However, press stories discounted the possibility of a deal between these two billion-dollar clinical pathology laboratory behemoths. Neither company has issued a public statement addressing this issue.
In assessing the possibility of Quest Diagnostics acquiring Sonic Healthcare, the Sydney Morning Herald (SMH) threw cold water on the idea. It pointed out that Sonic’s stock price is trading at a multiple of 10.8 times earnings before interest, taxes, depreciation, and amortization (EBITDA). That would make Sonic an expensive purchase for Quest Diagnostics, since Quest’s share price trades at a multiple of seven times EBITDA. Further, SMH’s reporter pointed out that Sonic’s market capitalization of A$5.7 billion would make it a major acquisition for Quest Diagnostics, which has a market capitalization of U.S.$9.5 billion.
(more…)
